EFPIA welcomes new EC structure, but others fear threat to data disclosure
This article was originally published in Scrip
Executive Summary
The European pharmaceutical industry federation EFPIA has welcomed the proposed new structure of the European Commission, which includes the transfer of responsibility for medicines and medical device regulation back to the directorate general for industry (DG ENTR).